ATE468158T1 - Diagnostische marker für krebs - Google Patents

Diagnostische marker für krebs

Info

Publication number
ATE468158T1
ATE468158T1 AT05707434T AT05707434T ATE468158T1 AT E468158 T1 ATE468158 T1 AT E468158T1 AT 05707434 T AT05707434 T AT 05707434T AT 05707434 T AT05707434 T AT 05707434T AT E468158 T1 ATE468158 T1 AT E468158T1
Authority
AT
Austria
Prior art keywords
cancer
activity
viii
protein
diagnostic
Prior art date
Application number
AT05707434T
Other languages
English (en)
Inventor
Michael Cahill
Helmut Klocker
Hermann Rogatsch
Original Assignee
Proteosys Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteosys Ag filed Critical Proteosys Ag
Priority claimed from PCT/EP2005/001567 external-priority patent/WO2005078124A2/de
Application granted granted Critical
Publication of ATE468158T1 publication Critical patent/ATE468158T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
AT05707434T 2004-02-16 2005-02-16 Diagnostische marker für krebs ATE468158T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004008449 2004-02-16
DE102004038076A DE102004038076A1 (de) 2004-02-16 2004-07-29 Diagnostische Marker für Krebs
PCT/EP2005/001567 WO2005078124A2 (de) 2004-02-16 2005-02-16 Diagnostische marker für krebs

Publications (1)

Publication Number Publication Date
ATE468158T1 true ATE468158T1 (de) 2010-06-15

Family

ID=34813531

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05707434T ATE468158T1 (de) 2004-02-16 2005-02-16 Diagnostische marker für krebs

Country Status (9)

Country Link
CN (1) CN101027099B (de)
AT (1) ATE468158T1 (de)
DE (2) DE102004038076A1 (de)
DK (1) DK1720611T3 (de)
ES (1) ES2345392T3 (de)
HR (1) HRP20100356T1 (de)
PT (1) PT1720611E (de)
RS (1) RS51391B (de)
SI (1) SI1720611T1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ588303A (en) * 2008-04-08 2012-05-25 Japan Science & Tech Agency Method for screening cattle, cattle screened, and cattle screening kit
GB0822836D0 (en) * 2008-12-15 2009-01-21 Oxford Biomedica Ltd Method
WO2013037118A1 (zh) * 2011-09-16 2013-03-21 上海长海医院 前列腺癌的生物学标志物、治疗靶点及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0000993D0 (en) * 2000-01-18 2000-03-08 Univ Nottingham Trent Cancer associated genes and their products
EP1272617B1 (de) * 2000-04-01 2011-04-27 Onyvax Limited Prostata zellinien und deren verwendung
WO2003009814A2 (en) * 2001-07-25 2003-02-06 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer

Also Published As

Publication number Publication date
RS51391B (en) 2011-02-28
ES2345392T3 (es) 2010-09-22
SI1720611T1 (sl) 2010-09-30
DK1720611T3 (da) 2010-09-06
DE102004038076A1 (de) 2005-09-01
CN101027099B (zh) 2013-04-03
DE502005009597D1 (de) 2010-07-01
HRP20100356T1 (hr) 2010-09-30
PT1720611E (pt) 2010-08-26
CN101027099A (zh) 2007-08-29

Similar Documents

Publication Publication Date Title
Didon et al. RFX3 modulation of FOXJ1 regulation of cilia genes in the human airway epithelium
Rabenold et al. Scratching the surface: a critique of Lucas et al.(2013)'s conclusion that phytoliths do not abrade enamel
Lange et al. Intracellular S-glutathionyl adducts in murine lung and human bronchoepithelial cells after exposure to diisocyanatotoluene
BRPI0411552A (pt) anticorpos especìficos a esclerostina e métodos para aumentar a mineralização óssea
RS49995B (sr) Primena dialkil fumarata
BRPI0417721A (pt) kit contendo um medicamento farmacêutico, métodos para preparar uma formulação lìquida de um polipeptìdeo de fator de coagulação sangüìnea e para tratar uma sìndrome responsiva a fator de coagulação, uso de um polipeptìdeo de fator vii, composição, e, métodos para preparar as composições e para tratar uma sìndrome responsiva a fvii
CL2008003572A1 (es) Molecula de acido nucleico que codifica para una proteina insecticida de la familia cry9; dicha proteina; casete de expresion que comprende dicha molecula de acido nucleico; y microorganismo transformado con dicha molecula; composicion plaguicida; y metodo para controlar un insecto plaga (div.sol. 3289-04).
NO20075077L (no) Fremgangsmate for a forbedre laering og hukommelse i pattedyr
NO20076024L (no) Anti-IL-6 antistoffer, sammensetninger, fremgangsmater og anvendelser
CO5721011A2 (es) Elementos de respuesta al estrogeno de bmp-2 y metodos de uso de los mismos
BRPI0514680A (pt) produção de anticorpos anti-amilóide beta
AR051523A1 (es) Metodo para medir la resistencia o sensibilidad a docetaxel
CY1113651T1 (el) Αντιφλεγμονωδη σκευασματα
WO2005010215A3 (en) Methods for identifying tolerance modulatory compounds and uses therefor
BR0316923A (pt) Polipeptìdeo mitoneet de membranas mitocondriais, seus moduladores e métodos para utilização do mesmo
ATE468158T1 (de) Diagnostische marker für krebs
BRPI0412971A (pt) método de alongamento do cabelo
DE60109272D1 (de) Verfahren zur reinigung von proteinen oder mischungen von proteinen und nukleinsäuren und so geschaffene zusammesetzungen von partikeln und proteinen
BR0214450A (pt) ácidos hidroxâmicos de sulfona aromáticos e uso dos mesmos como inibidores de protease
CY1111979T1 (el) Αντισωματα εναντιον nik, η παρασκευη και χρηση τους
Gedik et al. Proteomics/phosphoproteomics of left ventricular biopsies from patients with surgical coronary revascularization and pigs with coronary occlusion/reperfusion: remote ischemic preconditioning
BRPI0512336A (pt) métodos de diagnósticos para osteoporose
EP1343006A4 (de) Verfahren zur charakterisierung von proteinen
DE69710747T2 (de) Assays für homocystein und homocysteindesulfurase aus protozoen trichomonas vaginalis
ES2152107T3 (es) Uso de polisacaridos sulfatados en el tratamiento de heridas cronicas.